Cancer Treatment Reports 70(4): 469-472, 1986.

Trial of droperidol as an antiemetic in cisplatin chemotherapy.

Kelley SL, Braun TJ, Meyer TJ, et al.

Abstract:

A trial of droperidol as an antiemetic was undertaken during 48 courses of cisplatin chemotherapy in 31 patients with cancer. The optimal loading dose was 10 mg iv, with a maintenance dose of 4 mg iv every 2 hours for four additional doses. Beyond this level, cardiovascular side effects became problematic.

This is a service of:

Rheinische Friedrich- Wilhelms- Universität Bonn Medical Center

---